CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $374,000 | -10.5% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $418,000 | +11.2% | 19,000 | +20.3% | 0.01% | 0.0% |
| Q1 2021 | $376,000 | -9.0% | 15,800 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $413,000 | +36.3% | 15,800 | -9.2% | 0.01% | +28.6% |
| Q3 2020 | $303,000 | -43.4% | 17,400 | -61.8% | 0.01% | 0.0% |
| Q1 2019 | $535,000 | -34.8% | 45,600 | -25.7% | 0.01% | -36.4% |
| Q4 2018 | $820,000 | +88.5% | 61,400 | +98.1% | 0.01% | +175.0% |
| Q3 2018 | $435,000 | -10.7% | 31,000 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $487,000 | -4.5% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $510,000 | -22.3% | 31,000 | -14.6% | 0.01% | -28.6% |
| Q4 2017 | $656,000 | -10.1% | 36,300 | -4.0% | 0.01% | -12.5% |
| Q3 2017 | $730,000 | +19.7% | 37,800 | -26.9% | 0.01% | +14.3% |
| Q2 2017 | $610,000 | +7.6% | 51,700 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $567,000 | +51.2% | 51,700 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $375,000 | – | 51,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |